Quadrature Capital’s Bristol-Myers Squibb BMY Stock Holding History

Quadrature Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Sell	34,020 -134,138	-80%	-$7.7M	0.02%	509
2026 Q1	$10.2M	Sell	168,158 -13,551	-7%	-$790K	0.12%	148
2025 Q4	$9.8M	Sell	181,709 -350,727	-66%	-$16.9M	0.1%	153
2025 Q3	$24M	Buy	+532,436	New	+$24.9M	0.28%	79
2025 Q2	–	Sell	-44,319	Closed	-$2.7M	–	1062
2025 Q1	$2.7M	Buy	+44,319	New	+$2.58M	0.06%	251
2023 Q3	–	Sell	-9,254	Closed	-$592K	–	1002
2023 Q2	$592K	Buy	+9,254	New	+$621K	0.01%	542
2021 Q3	–	Sell	-17,028	Closed	-$1.14M	–	712
2021 Q2	$1.14M	Sell	17,028 -94,643	-85%	-$6.17M	0.04%	285
2021 Q1	$7.05M	Buy	111,671 +64,411	+136%	+$4.01M	0.34%	69
2020 Q4	$2.93M	Buy	+47,260	New	+$2.91M	0.14%	119
2020 Q2	–	Sell	-13,403	Closed	-$747K	–	617
2020 Q1	$747K	Buy	+13,403	New	+$819K	0.18%	162
2019 Q2	–	Sell	-469,684	Closed	-$22.4M	–	452
2019 Q1	$22.4M	Buy	469,684 +425,046	+952%	+$21.2M	1.92%	5
2018 Q4	$2.32M	Buy	44,638 +16,546	+59%	+$889K	0.42%	64
2018 Q3	$1.74M	Buy	+28,092	New	+$1.67M	0.14%	168
2018 Q2	–	Sell	-78,193	Closed	-$4.95M	–	527
2018 Q1	$4.95M	Buy	78,193 +30,006	+62%	+$1.93M	0.39%	70
2017 Q4	$2.96M	Sell	48,187 -8,038	-14%	-$503K	0.26%	105
2017 Q3	$3.58M	Buy	56,225 +13,622	+32%	+$795K	0.45%	50
2017 Q2	$2.37M	Sell	42,603 -323,867	-88%	-$17.6M	0.18%	127
2017 Q1	$19.9M	Buy	366,470 +25,092	+7%	+$1.38M	1.43%	5
2016 Q4	$20M	Buy	341,378 +222,514	+187%	+$12.2M	0.63%	36
2016 Q3	$6.41M	Buy	+118,864	New	+$7.64M	0.56%	45
2015 Q4	–	Sell	-16,000	Closed	-$947K	–	441
2015 Q3	$947K	Buy	+16,000	New	+$1.02M	0.32%	103

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quadrature Capital's BMY Position: Q2 2026 in Review

Quadrature Capital reduced its Bristol-Myers Squibb (BMY) stake by 80% in Q2 2026, selling an estimated $7.7M and leaving 34,020 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #509.

Quadrature Capital first reported a position in BMY in Q3 2015 and has held it in 21 quarters since. The position peaked at $24M in Q3 2025. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Quadrature Capital held 34,020 shares of Bristol-Myers Squibb worth $1.96M as of Q2 2026.
Quadrature Capital sold 134,138 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.7M.
Bristol-Myers Squibb made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #509 holding.
Quadrature Capital first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 21 quarters since.
Quadrature Capital's Bristol-Myers Squibb position peaked at $24M in Q3 2025.
2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.